Overview

Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension

Status:
Completed

Trial end date:
2007-09-01

Target enrollment:

Participant gender:

Summary

This randomized study will compare the effect of lumiracoxib, ibuprofen and placebo on 24-hour blood pressure profile and on urinary excretions of eicosanoids in controlled hypertensive patients who have osteoarthritis.

Phase:

Phase 4

Details

Lead Sponsor:

Novartis

Treatments:

Diclofenac
Ibuprofen
Lumiracoxib